BIOCON.BOBIOCON.BOBSE
Loading
Year-over-year operating income growth rate
Percentile
P28
Within normal range
vs 5Y Ago
-2x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -12.20% |
| Q3 2025 | -78.29% |
| Q2 2025 | 1040.34% |
| Q1 2025 | -110.83% |
| Q4 2024 | 4.19% |
| Q3 2024 | 7.60% |
| Q2 2024 | 632.67% |
| Q1 2024 | -113.73% |
| Q4 2023 | 17.02% |
| Q3 2023 | 4.92% |
| Q2 2023 | 493.05% |
| Q1 2023 | -132.14% |
| Q4 2022 | 38.39% |
| Q3 2022 | 25.48% |
| Q2 2022 | 195.56% |
| Q1 2022 | -193.49% |
| Q4 2021 | 17.65% |
| Q3 2021 | 11.89% |
| Q2 2021 | 105133.33% |
| Q1 2021 | -99.92% |
| Q4 2020 | 6.17% |
| Q3 2020 | 6.00% |
| Q2 2020 | 295.43% |
| Q1 2020 | -76.51% |
| Q4 2019 | 7.39% |
| Q3 2019 | 4.16% |
| Q2 2019 | 947.35% |
| Q1 2019 | -90.80% |
| Q4 2018 | 30.76% |
| Q3 2018 | 37.03% |
| Q2 2018 | 11.16% |
| Q1 2018 | 8.24% |
| Q4 2017 | 11.82% |
| Q3 2017 | 5.17% |
| Q2 2017 | 145.08% |
| Q1 2017 | -379.15% |
| Q4 2016 | 19.86% |
| Q3 2016 | -12.84% |
| Q2 2016 | 146.53% |
| Q1 2016 | -433.39% |